Clinical Data, Inc.

Stock Information
CLDA - (NASD) $16.68 + 0.55	Jul 23, 2008 4:00 PM ET

Overview

Clinical Data, Inc. is a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care.

The Company is organized under two worldwide divisions segmented by service offerings and varying client constituents: PGxHealth™ and Cogenics™.

Clinical Data’s genetic test division, PGxHealth™, builds upon existing assets and know-how acquired from Genaissance Pharmaceuticals in the areas of genomics-based tests and therapeutic efficacy and safety biomarker development for drug utilization. PGxHealth plans to develop and introduce novel genetic tests that the division has branded Therapeutic Diagnostics™ in some instances in combination with new and existing therapeutics.
Clinical Data’s Pharmacogenomics and Molecular Services™ division, Cogenics™, consolidates the operations of Genaissance Pharmaceuticals, Inc., Lark Technologies, Inc. and Icoria, Inc., each acquired during 2005, and Genome Express SA, acquired in 2006. Cogenics provides a comprehensive range of molecular and pharmacogenomics services to pharmaceutical, biotech, academia, agricultural, and government clients. These services are offered in both research and regulated environments and have applications across the lifecycle of pharmaceutical product development including pharmacovigilance requirements post-launch.

Clinical Data currently employs a staff of over 300. The Company is headquartered in Newton, Massachusetts with operations in Texas, Connecticut and Research Triangle Park, North Carolina, as well as internationally in Germany, France and the UK. Furthermore, Clinical Data has numerous distribution, licensing, development and other collaborations with key partners.